{"id":"https://openalex.org/W2398537899","doi":null,"title":"Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats.","display_name":"Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2398537899","mag":"2398537899","pmid":"https://pubmed.ncbi.nlm.nih.gov/18799822"},"language":"en","primary_location":{"id":"pmid:18799822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18799822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2398537899"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018215833","display_name":"Hani Al\u2010Salami","orcid":"https://orcid.org/0000-0003-0049-6969","observed_orcids":["https://orcid.org/0000-0003-0049-6969"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Hani Al-Salami","raw_affiliation_strings":["School of Pharmacy, University of Otago, Frederick 18, Dunedin 9054, PO Box 913, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Otago, Frederick 18, Dunedin 9054, PO Box 913, New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036969238","display_name":"Grant Butt","orcid":"https://orcid.org/0000-0002-0224-8806","observed_orcids":["https://orcid.org/0000-0002-0224-8806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grant Butt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085725409","display_name":"Ian G. Tucker","orcid":"https://orcid.org/0000-0002-3304-6377","observed_orcids":["https://orcid.org/0000-0002-3304-6377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian Tucker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026540507","display_name":"Momir Mikov","orcid":"https://orcid.org/0000-0002-2804-0624","observed_orcids":["https://orcid.org/0000-0002-2804-0624"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Momir Mikov","raw_affiliation_strings":["Univ of Otago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Otago","institution_ids":["https://openalex.org/I80281795"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0232,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.7677714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"60","issue":"4","first_page":"532","last_page":"541"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8560000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8560000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.06960000097751617,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.6539999842643738},{"id":"https://openalex.org/keywords/mrp3","display_name":"MRP3","score":0.8429999947547913},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8320000171661377},{"id":"https://openalex.org/keywords/alloxan-induced-diabetes","display_name":"alloxan-induced diabetes","score":0.9760000109672546},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9599999785423279},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.6710000038146973},{"id":"https://openalex.org/keywords/intestinal-drug-absorption","display_name":"intestinal drug absorption","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2777448766","wikidata":"https://www.wikidata.org/wiki/Q290001","display_name":"Gliclazide","level":3,"score":0.9927643537521362},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.7800570726394653},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.6372063159942627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5663431882858276},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.5425233840942383},{"id":"https://openalex.org/C382228","wikidata":"https://www.wikidata.org/wiki/Q849994","display_name":"Clinical chemistry","level":2,"score":0.5253450274467468},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5235002636909485},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5226183533668518},{"id":"https://openalex.org/C2781005915","wikidata":"https://www.wikidata.org/wiki/Q417701","display_name":"Alloxan","level":3,"score":0.5156044363975525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4782915711402893},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4766871929168701},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.44781023263931274},{"id":"https://openalex.org/C2779399885","wikidata":"https://www.wikidata.org/wiki/Q413288","display_name":"Bile acid","level":2,"score":0.42895135283470154},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4239705801010132},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.15031546354293823},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.12884849309921265},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12164613604545593},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005907","descriptor_name":"Gliclazide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18799822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18799822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"mag:2398537899","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18799822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W139735219","https://openalex.org/W232092809","https://openalex.org/W1536422180","https://openalex.org/W1539481967","https://openalex.org/W1849728743","https://openalex.org/W1934547775","https://openalex.org/W1938701462","https://openalex.org/W1966514588","https://openalex.org/W1968650808","https://openalex.org/W1972374067","https://openalex.org/W1975669908","https://openalex.org/W1979878488","https://openalex.org/W1980170993","https://openalex.org/W1981002646","https://openalex.org/W1984613701","https://openalex.org/W1985004470","https://openalex.org/W1989915286","https://openalex.org/W2000067128","https://openalex.org/W2000256468","https://openalex.org/W2001838995","https://openalex.org/W2008493682","https://openalex.org/W2012334764","https://openalex.org/W2026699101","https://openalex.org/W2027342488","https://openalex.org/W2028899000","https://openalex.org/W2031804700","https://openalex.org/W2040628852","https://openalex.org/W2042066665","https://openalex.org/W2042151800","https://openalex.org/W2046867471","https://openalex.org/W2047527636","https://openalex.org/W2050969206","https://openalex.org/W2051215695","https://openalex.org/W2068406006","https://openalex.org/W2069202991","https://openalex.org/W2070128851","https://openalex.org/W2071590632","https://openalex.org/W2077937196","https://openalex.org/W2097429326","https://openalex.org/W2101686121","https://openalex.org/W2103678961","https://openalex.org/W2108941037","https://openalex.org/W2110790042","https://openalex.org/W2111021589","https://openalex.org/W2113544353","https://openalex.org/W2117571897","https://openalex.org/W2117927958","https://openalex.org/W2123467745","https://openalex.org/W2130034040","https://openalex.org/W2137715148","https://openalex.org/W2145766137","https://openalex.org/W2148917087","https://openalex.org/W2150435134","https://openalex.org/W2156663446","https://openalex.org/W2167340002","https://openalex.org/W2171167058","https://openalex.org/W2409698811","https://openalex.org/W2414418676","https://openalex.org/W2416666745","https://openalex.org/W2952500102"],"related_works":["https://openalex.org/W2030268987","https://openalex.org/W2034695786","https://openalex.org/W2795181120","https://openalex.org/W2064289043","https://openalex.org/W1847367967","https://openalex.org/W1995688013","https://openalex.org/W6893247466","https://openalex.org/W3112512770","https://openalex.org/W7117250470"],"abstract_inverted_index":{"The":[0,201],"aim":[1],"of":[2,24,45,69,88,119,144,149,161,188,195,203,207,215,217,224,230,236,245,249],"this":[3],"study":[4],"is":[5],"to":[6,52,59,65,79,108,141,167,171,232],"investigate":[7],"how":[8],"the":[9,21,25,67,86,113,117,139,147,159,193,213,222,243,246],"semisynthetic":[10],"bile":[11],"acid;":[12],"3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate,":[13],"also":[14],"known":[15],"as":[16],"12-monoketocholic":[17],"acid":[18],"(MKC)":[19],"influences":[20],"ileal":[22],"permeation":[23,68,82,143,160],"antidiabetic":[26],"drug":[27,218],"gliclazide":[28,70,81,145,162,189,208],"in":[29,76,85,112,138,146,163,180,209,238],"healthy":[30,49,131,239],"and":[31,54,98,156,169,173],"diabetic":[32,56,181,210],"rats.":[33],"Male":[34],"Wistar":[35],"rats":[36,50,57,211],"were":[37,110],"divided":[38],"into":[39],"10":[40,109],"groups":[41,77],"(n":[42],"=":[43],"32),":[44],"which":[46],"5":[47,55,80],"comprised":[48],"(1":[51],"5)":[53],"(6":[58],"10).":[60],"Group":[61],"1":[62,121],"was":[63,83,134,184],"used":[64],"measure":[66],"(200":[71],"microg/ml)":[72],"alone":[73,190],"(control)":[74],"while":[75,154],"2":[78],"measured":[84],"presence":[87,148],"MKC":[89,150],"(50":[90],"microg/ml),":[91,101],"glibenclamide":[92,155],"(100":[93,96],"mug/ml),":[94],"rifampicin":[95,157,198],"mug/ml)":[97],"verapamil":[99,174],"(30":[100],"respectively,":[102],"using":[103],"Ussing":[104],"chambers.":[105],"Groups":[106],"6":[107],"treated":[111],"same":[114],"way,":[115],"after":[116,192],"induction":[118],"type":[120],"diabetes":[122],"with":[123],"alloxan":[124],"(iv":[125],"30":[126],"mg/kg).":[127],"In":[128,178],"tissues":[129],"from":[130],"rats,":[132,182,240],"there":[133,183],"a":[135],"9-fold":[136],"reduction":[137],"mucosal":[140,166,172,231],"serosal":[142,168,170,233],"(p":[151],"<":[152],"0.001)":[153],"reduced":[158],"both":[164],"directions;":[165],"had":[175],"no":[176,185],"effect.":[177],"contrast,":[179],"net":[186,205],"transport":[187],"or":[191,199,221],"addition":[194],"MKC,":[196],"glibenclamide,":[197],"verapamil.":[200],"lack":[202,214],"any":[204],"flux":[206,235],"suggests":[212],"action":[216],"transporters":[219],"involved":[220],"suppression":[223],"their":[225],"expression.":[226],"Furthermore,":[227],"MKC-induced":[228],"inhibition":[229,248],"unidirectional":[234],"gliclazide,":[237],"can":[241],"be":[242],"result":[244],"selective":[247],"Mrp3.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2398537899","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
